Skip to main content
Bambusa Therapeutics, Inc. (BBTX)
NASDAQ: BBTX · Real-Time Price · USD
17.50
+0.34 (1.98%)
Nov 12, 2026, 9:36 AM EST - Market open

Bambusa Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Jun '26 Dec '25 Dec '24
Net Income
-48.7-41.09-16.49
Loss (Gain) From Sale of Investments
-0.26-0.2-
Stock-Based Compensation
1.545.380.23
Other Operating Activities
-0.160.38-0.01
Change in Accounts Payable
1.51.910.02
Change in Other Net Operating Assets
5.18-6.1910.69
Operating Cash Flow
-40.9-39.8-5.56
Operating Cash Flow Growth
---

Investing Activities

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Jun '26 Dec '25 Dec '24
Investment in Securities
-24.7-39.73-
Investing Cash Flow
-24.7-39.73-

Financing Activities

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Jun '26 Dec '25 Dec '24
Issuance of Common Stock
0.030.03-
Other Financing Activities
-0.08-0.17-0.12
Financing Cash Flow
33.02120.8116.8

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Jun '26 Dec '25 Dec '24
Net Cash Flow
-32.5841.2811.23

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Jun '26 Dec '25 Dec '24
Levered Free Cash Flow
--22.83-
Unlevered Free Cash Flow
--22.83-

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Jun '26 Dec '25 Dec '24
Change in Working Capital
6.68-4.2810.71
SEC Filings: 10-K · 10-Q